HIM
RGEN icon

Hillsdale Investment Management’s Repligen RGEN Stock Holding History

Hillsdale Investment Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40
Closed -$8K – 639
2021
Q1 		$8K Hold
40
– – ﹤0.01% 517
2020
Q4 		$8K Buy
+40
New +$7.28K ﹤0.01% 526
2020
Q3 		– Sell
-6,300
Closed -$779K – 639
2020
Q2 		$779K Sell
6,300
-1,000
-14% -$118K 0.07% 229
2020
Q1 		$705K Sell
7,300
-1,900
-21% -$183K 0.08% 211
2019
Q4 		$851K Hold
9,200
– – 0.07% 240
2019
Q3 		$706K Buy
+9,200
New +$805K 0.06% 278

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Hillsdale Investment Management's RGEN Position: Q2 2021 in Review

Hillsdale Investment Management sold out of Repligen (RGEN) in Q2 2021, closing a stake of 40 shares — an estimated $8K sold.

Hillsdale Investment Management first reported a position in RGEN in Q3 2019 and held it in 6 quarters. The position peaked at $851K in Q4 2019. 429 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.

  • Hillsdale Investment Management reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
  • Hillsdale Investment Management sold 40 Repligen shares in Q2 2021, an estimated $8K.
  • Hillsdale Investment Management first reported a position in Repligen in Q3 2019 and held it in 6 quarters.
  • Hillsdale Investment Management's Repligen position peaked at $851K in Q4 2019.
  • 429 funds tracked by Wall St. Rank held Repligen as of Q2 2021.

Based on Hillsdale Investment Management's 13F filing for Q2 2021, filed 29 Jul 2021.